ATE204569T1 - PIPERAZINE-2,5-DIONE DERIVATIVES AS MULTIDRUG RESISTANCE MOLDULATORS - Google Patents

PIPERAZINE-2,5-DIONE DERIVATIVES AS MULTIDRUG RESISTANCE MOLDULATORS

Info

Publication number
ATE204569T1
ATE204569T1 AT95941799T AT95941799T ATE204569T1 AT E204569 T1 ATE204569 T1 AT E204569T1 AT 95941799 T AT95941799 T AT 95941799T AT 95941799 T AT95941799 T AT 95941799T AT E204569 T1 ATE204569 T1 AT E204569T1
Authority
AT
Austria
Prior art keywords
pct
moldulators
piperazine
formula
multidrug resistance
Prior art date
Application number
AT95941799T
Other languages
German (de)
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Application granted granted Critical
Publication of ATE204569T1 publication Critical patent/ATE204569T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Abstract

PCT No. PCT/GB95/03029 Sec. 371 Date Aug. 29, 1997 Sec. 102(e) Date Aug. 29, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/20180 PCT Pub. Date Jul. 4, 1996A piperazinedione of general formula (I): wherein R1 is selected from hydrogen; a group of formula -(NH)t-COR3 wherein t is 0 or 1 and R3 is an organic substituent as defined herein; a group of formula (D): and a group of formula (E): and the pharmaceutically acceptable salts thereof are useful as modulators of multi-drug resistance.
AT95941799T 1994-12-23 1995-12-22 PIPERAZINE-2,5-DIONE DERIVATIVES AS MULTIDRUG RESISTANCE MOLDULATORS ATE204569T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426090.8A GB9426090D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003029 WO1996020180A1 (en) 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as modulators of multidrug resistance

Publications (1)

Publication Number Publication Date
ATE204569T1 true ATE204569T1 (en) 2001-09-15

Family

ID=10766502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941799T ATE204569T1 (en) 1994-12-23 1995-12-22 PIPERAZINE-2,5-DIONE DERIVATIVES AS MULTIDRUG RESISTANCE MOLDULATORS

Country Status (28)

Country Link
US (1) US5935955A (en)
EP (1) EP0799210B1 (en)
JP (1) JPH10511385A (en)
KR (1) KR100412167B1 (en)
CN (1) CN1108294C (en)
AT (1) ATE204569T1 (en)
AU (1) AU700891B2 (en)
BG (1) BG63305B1 (en)
BR (1) BR9510429A (en)
CA (1) CA2207548A1 (en)
CZ (1) CZ288935B6 (en)
DE (1) DE69522342T2 (en)
DK (1) DK0799210T3 (en)
ES (1) ES2160726T3 (en)
FI (1) FI972661A (en)
GB (2) GB9426090D0 (en)
HK (1) HK1001974A1 (en)
HU (1) HUT77740A (en)
IL (1) IL116526A (en)
MY (1) MY131762A (en)
NO (1) NO308532B1 (en)
NZ (1) NZ297849A (en)
PL (1) PL186851B1 (en)
PT (1) PT799210E (en)
SK (1) SK283385B6 (en)
UA (1) UA61879C2 (en)
WO (1) WO1996020180A1 (en)
ZA (1) ZA9510908B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
CO5140073A1 (en) 1998-10-08 2002-03-22 Smithkline Beecham Plc DERIVATIVES OF 2,3,4,5-TETRAHIDRO-1H-3-BENZAPINA
US6828412B1 (en) * 1999-09-03 2004-12-07 School Of Pharmacy, University Of London Degradable polymers
AU7346400A (en) * 1999-09-03 2001-04-10 School Of Pharmacy, University Of London, The Degradable polymers
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU2001288829A1 (en) 2000-09-06 2002-03-22 Ap Pharma, Inc. Degradable polyacetal polymers
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
CA2465886A1 (en) * 2001-11-07 2003-05-15 Kathleen S. Crowley Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
US8710062B2 (en) * 2011-03-11 2014-04-29 Taipei Medical University Piperazinedione compounds
CN103396372B (en) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 2,5-diketopiperazine derivative, as well as preparation method and application thereof in preparing control agent for resisting marine fouling organisms
KR102468480B1 (en) * 2018-12-27 2022-11-18 홀로스메딕 주식회사 Novel compounds for enhancing anti-cancer activity and pharmaceutical composition thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152443T1 (en) * 1992-07-10 1997-05-15 Glaxo Lab Sa ANILIDE DERIVATIVES
US5460977A (en) * 1992-08-14 1995-10-24 Torii & Co. Peptide having allergenicity
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
HK1001974A1 (en) 1998-07-24
GB9712179D0 (en) 1997-08-13
PL320915A1 (en) 1997-11-10
PL186851B1 (en) 2004-03-31
DK0799210T3 (en) 2001-10-01
EP0799210B1 (en) 2001-08-22
NZ297849A (en) 1999-04-29
AU700891B2 (en) 1999-01-14
GB2311780B (en) 1999-03-03
WO1996020180A1 (en) 1996-07-04
IL116526A (en) 1999-11-30
DE69522342D1 (en) 2001-09-27
EP0799210A1 (en) 1997-10-08
GB2311780A (en) 1997-10-08
BG63305B1 (en) 2001-09-28
PT799210E (en) 2002-01-30
DE69522342T2 (en) 2002-01-03
CZ288935B6 (en) 2001-09-12
CZ190297A3 (en) 1998-01-14
NO972938L (en) 1997-06-23
HUT77740A (en) 1998-07-28
CN1176637A (en) 1998-03-18
US5935955A (en) 1999-08-10
KR100412167B1 (en) 2004-05-27
FI972661A0 (en) 1997-06-19
ES2160726T3 (en) 2001-11-16
MY131762A (en) 2007-08-30
SK283385B6 (en) 2003-06-03
AU4310296A (en) 1996-07-19
GB9426090D0 (en) 1995-02-22
BG101601A (en) 1998-02-27
FI972661A (en) 1997-08-22
JPH10511385A (en) 1998-11-04
IL116526A0 (en) 1996-03-31
NO308532B1 (en) 2000-09-25
ZA9510908B (en) 1996-06-24
SK83597A3 (en) 1998-04-08
NO972938D0 (en) 1997-06-23
CA2207548A1 (en) 1996-07-04
UA61879C2 (en) 2003-12-15
BR9510429A (en) 1998-07-07
CN1108294C (en) 2003-05-14

Similar Documents

Publication Publication Date Title
DE69327541T2 (en) 4-ARYLMETHYLOXYMETHYL PIPERIDINE AS TACHYKININ ANTAGONISTS
DE69425162T2 (en) 4,5-DIARYLOXAZOLE DERIVATIVES
EA199800141A1 (en) HETEROCYCLIC COMPOUNDS
ATE204569T1 (en) PIPERAZINE-2,5-DIONE DERIVATIVES AS MULTIDRUG RESISTANCE MOLDULATORS
ATE155133T1 (en) PIPERAZINE DERIVATIVES AS 5-HT ANTAGONISTS
EP1184373A4 (en) Tricyclic compounds
ES2123756T3 (en) PIPERAZINE DERIVATIVES.
DE69719511D1 (en) ANTIVIRAL 2,4-PYRIMIDINDION DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EP1130015A4 (en) Pyridazinone derivatives
DE69332019T2 (en) 4-OXO AND 4H-IMIDAZO (5,1-C) (1,4) BENZOXAZINE USEFUL AS A BENZODIAZEPINE RECEPTOR BINDING AGENT.
ATE202108T1 (en) CEPHEMEM COMPOUNDS
BR9812928B1 (en) 3-oxo- (2h) -1,2,4-triazine derivatives, compounds, process for preparing chemical compounds, and pharmaceutical composition.
TR199701289T2 (en) Esters of carbapenems

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee